Loading organizations...
§ Private Profile · San Francisco, CA, USA
AI-driven clinical decision support software for healthcare systems, improving diagnostics and preventing medication errors.
San Francisco, California-based Aesop Technology develops AI-driven clinical decision support software that integrates directly into electronic health records to assist healthcare systems with diagnostic accuracy, medication error prevention, and medical billing. Operating as a B2B enterprise SaaS provider, the company licenses its machine learning platforms, including its flagship DxPrime software tool, to hospitals, clinics, and physician networks. The enterprise operates with an estimated headcount of fewer than fifty employees across its United States headquarters and its research and development center in Taipei, Taiwan. Aesop Technology raised 2,950,000 dollars in seed funding through a May 2021 financing round led by Wistron Corporation, with additional backing from SparkLabs Taipei and the Berkeley SkyDeck accelerator program during Cohort 11. The company was founded in 2019 by chief executive officer Jim Long alongside co-founders Jer-Hao Chang and Yin-Yin Chen.
Aesop Technology has raised $3.0M across 1 funding round.
Aesop Technology has raised $3.0M in total across 1 funding round.
Aesop Technology has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Pre-Series A in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2022 | $3M Seed Plus | — | 500 Startups, BE Capital, Colopl Next | Announced |
Aesop Technology has raised $3.0M in total across 1 funding round.
Aesop Technology's investors include 500 Startups, BE Capital, Colopl Next.